(2S,5R)-7-oxo-N-(4-piperidinyl)-6-(sulfooxy)-1,6-diazabicyclo(3.2.1)octane-2-carboxamide,
MK-7655,
MK7655,
relebactam,
relebactam anhydrous,
Relebactam,
1174018-99-5,
MK-7655,
Relebactam anhydrous,
UNII-1OQF7TT3PF,
1OQF7TT3PF,
CHEMBL3112741,
Sulfuric acid, mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester,
Relebactam [INN],
MK7655,
MK 7655,
(-)-Relebactam anhydrous,
BDBM1858,
SCHEMBL3721178,
EX-A864,
SMOBCLHAZXOKDQ-ZJUUUORDSA-N,
MK-7655A,
BDBM50447651,
MFCD28502833,
ZINC43206319,
CS-5391,
DB12377,
SB16968,
AS-35205,
HY-16752,
Sulfuric acid mono-((2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diaza-bicyclo(3.2.1)oct-6-yl) ester,
US8487073, 1A,
J3.628.086G,
KS-00000649,
MK-7655;MK7655;MK 7655,
J-690043,
(2S,5R)-7-oxo-N-piperidin-4-yl-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide,
D02VSP,
N-{2-[(5-Fluoro-2-{[2-methoxy-4-(4-morpholinyl)phenyl]amino}-4-pyrimidinyl)amino]phenyl}methanesulfonamide,
Sulfuric acid mono-[7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diaza-bicyclo[3.2.1]oct-6-yl] ester,
Sulfuric acid mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester,